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Abstract. Dynamic reductive kinetic resolutions of racemic 
3-aryl-alkanones have been performed by the proper 
combination of an alcohol dehydrogenase and a basic 
anionic resin. The best results were found for the 
bioreduction with the alcohol dehydrogenase type A from 
Rhodococcus ruber DSM 44541 overexpressed in 
Escherichia coli (E. coli/ADH-A) and the commercially 
available evo-1.1.200, while the Amberlite IRA-440 C and 
the DOWEX-MWA-1 resins allowed efficient in situ 
racemizations. Reaction conditions were optimized in terms 
of enzyme source and loading, type and amount of resin, pH,  
temperature and reaction times, obtaining a series of (R,R)-
substituted propan-2-ols with good conversions and both 
diastero- and stereoselectivity. As a proof of concept, the 
subsequent intramolecular cyclization of a selected propan-
2-ol substrate afforded a valuable isochroman heterocycle 
without any loss of the optical purity. 
Keywords: Alcohol dehydrogenases; Dynamic processes; 
Dynamic reductive kinetic resolutions; Ion exchange resins; 
Ketones 
 
Introduction 
Dynamic kinetic resolutions (DKRs) provide 
significant advantages in synthetic chemistry leading 
to enantiopure compounds in theoretically maximum 
100% yield.1 In this context, the use of enzymes has 
been extensively explored for the selective 
modification of one enantiomer while the unreacted 
substrate enantiomer is racemized using either 
biological or chemocatalysts, or even through a 
spontaneous process. Thus, the DKRs of racemic 
alcohols, amines and their derivatives have been 
achieved with excellent selectivity levels mainly 
using hydrolases.2 Redox enzymes have also been 
presented along recent years as ideal catalysts for the 
development of dynamic processes.3 In this context, 
alcohol dehydrogenases are valuable tools for the 
selective bioreduction of ketones, obtaining valuable 
alcohols with one or multiple stereocenters.4 
Consequently, the racemization of the untouched 
stereocenter is possible, enabling the generation of 
multiple stereocenters in a single reaction. This 
epimerizable stereocenter is normally located in the 
adjacent position of the carbonyl group, bearing an 
acidic proton that facilitates the racemization, leading 
to the development of the so-called dynamic 
reductive kinetic resolutions (DYRKRs).5 
In our continuous efforts to develop efficient one-
pot transformations for the design of dynamic 
processes using redox enzymes, the synthesis of a 
series of racemic 3-aryl-alkan-2-ones was performed, 
to later explore the combination of ADHs under basic 
conditions for the development of DYRKRs.6 This 
chemoenzymatic strategy provides access to 
enantioenriched alcohols, immediate precursors of 
enantio- and diastereomerically pure 3,4-
dihydroisocoumarines by intramolecular cyclization 
processes (Scheme 1). Herein, we wish to expand the 
synthetic possibilities of this methodology using 
different benzyl ketones as starting materials, in order 
to obtain new families of privileged heterocyclic 
structures such as isochromanes,7 through a 
chemoenzymatic and asymmetric strategy. 
Isochromanes represent an interesting family of 
compounds due to their cytotoxicity properties and 
high value as building blocks or more complex 
structures. 
 
Scheme 1. Synthesis of different heterocyclic scaffolds 
from benzyl ketones in a sequential dynamic bioreduction 
and intramolecular cyclization. 
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Results and Discussion 
A series of racemic -substituted benzyl ketones 2a-
m were prepared by reacting the prochiral ketones 
1a-g with alkyl iodides in the presence of 
equimolecular amounts of tetrabutylammonium 
bisulfate (Table 1). Based on the commercial 
availability of benzyl ketones, different pattern 
substitutions were considered for the aromatic ring 
such as methoxy, hydroxy, nitro or fluoro rests in 
orto and para position (entries 1-7), but also a broad 
selection of alkyl iodides were tested from linear 
aliphatic reagents (methyl, ethyl, propyl, allyl and 
butyl chains, entries 1-7, 8, 9, 10 and 11) to 
cyclohexyl (entry 12) and benzyl (entry 13). After 2 h 
at 40 ºC, the corresponding alkylated ketones 2a-m 
were obtained with moderate to high yields after an 
extraction and a column chromatography purification 
(30-84%). Then, in order to find suitable conditions 
for the measurement of conversion and enantiomeric 
excess values for the bioreduction processes, the 
chemical reduction of the so-obtained benzyl ketones 
was performed by reaction with sodium borohydride 
in methanol, yielding the alcohols 3a-m in very high 
yields (90-99%). The anti-configurations were 
favoured in all cases (up to 13:87 diastereomeric ratio 
syn:anti). 
Table 1. Synthesis of ketones 2a-m through alkylation 
reaction of 1a-g with alkyl iodides, and subsequent 
chemical reduction towards the formation of racemic 
alcohols 3a-m. 
 
Entry 3 R1 R2 2a-m 
(%)a 
3a-m 
(%)a,b 
1 3a H Me 67 93 (20:80) 
2 3b 4-OMe Me 60 96 (16:84) 
3 3c 4-OH Me 45 93 (14:86) 
4 3d 4-NO2 Me 67 96 (23:77) 
5 3e 2-OMe Me 55 99 (13:87) 
6 3f 2-Me Me 55 90 (13:87) 
7 3g 2-F Me 84 97 (16:84) 
8 3h H Et 56 97 (19:81) 
9 3i H n-Pr 49 98 (15:85) 
10 3j H Allyl 54 98 (21:79) 
11 3k H n-Bu 60 95 (14:86) 
12 3l H Cy 30 90 
13 3m H Bn 40 96 
a Isolated yields (See further details in the experimental 
section). 
b Diastereomeric ratios syn:anti measured by GC analysis 
appear in parentheses (see Supporting Information for 
further details). No data are reported for 3l and 3m as 
adequate analytical were not found for the determination of 
the dr. 
The less substituted substrate from this series, 3-
phenylbutan-2-one (2a) was chosen as model 
substrate for the development of bioreduction 
processes. Initially, KR and racemization experiments 
were independently conducted trying to find adequate 
conditions aiming the later combinations of both 
processes in order to explore and compare the 
possibilities of DYRKR with previous benzyl 
ketones,6 but now lacking of a cyano group in the C-
2ʹ position (Table 2). Based on our previous findings, 
the Rhodococcus ruber DSM 44541 overexpressed in 
Escherichia coli (E. coli/ADH-A),8 was used 
considering its potential for the bioreduction of those 
benzyl ketones.6 Surprisingly, high conversion 
values and then poor diasteroselectivities were found 
after 24 h at 30 ºC using either 5 or 15 mg of enzyme 
loading (entries 1 and 2). This is in contrast with the 
moderate conversion associated to an excelent 
enantio- and diastereoselectivity found for the C-2 
substituted ketone namely 2-(3-oxobutan-2-
yl)benzonitrile (41% conversion, >99:<1 dr).6 
Table 2. Bioreduction of ketone 2a using E. coli/ADH-A 
in a Tris-HCl buffer pH 7.5 at 250 rpm. 
 
Entry T (ºC) t ADH-A (mg) c (%)a drb 
1 30 24 h 15 96 53:47 
2 30 24 h 5 98 53:47 
3 30 5 min 15 19 91:9 
4 30 10 min 15 41 87:13 
5 30 20 min 15 52 82:18 
6 30 40 min 15 70 70:30 
7 30 1 h 15 75 63:37 
8 30 2 h 15 88 54:46 
9 30 5 min 5 12 93:7 
10 30 10 min 5 21 91:9 
11 30 20 min 5 30 89:11 
12 30 40 min 5 49 82:18 
13 4 5 min 5 8 90:10 
14 4 10 min 5 12 90:10 
15 4 20 min 5 16 90:10 
16 4 40 min 5 20 90:10 
17 4 1 h 5 26 90:10 
18 4 2 h 5 41 89:11 
19 4 4 h 5 53 83:17 
20 4 6 h 5 64 76:24 
a Conversion values measured by GC analysis (see 
Supporting Information for further details) 
b Diastereomeric ratios syn:anti measured by GC analysis 
(see Supporting Information for further details) 
A series of experiments were carried out to 
understand the reaction outcome, considering shorter 
reaction times for a selectivity improvement. As it 
can be seen the use of 15 mg (entries 3-8) or 5 mg of 
enzyme (entries 9-12) at 4 (entries 13-20) or 30 ºC 
(entries 3-12), led to good selectivity values at short 
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reaction times (up to 83:17 dr) for conversion values 
closed to 50% (entries 5, 12 and 19). Reducing the 
bioreduction kinetics would allow a good DYRKR 
always that a highly faster racemization kinetic could 
be achieved (see enantiomeric excess of ketone 2a in 
the Supporting information for the reaction at 4 ºC). 
In contrast with the non enzymatic bioreduction 
performed with NaBH4, now the formation of the 
syn-diastereomer was favoured. In all cases the (S,S)-
alcohol was identified as the major diasteroisomer by 
HPLC analysis. 
Next, conditions for the dynamic process were 
implemented based on the presence of an acidic -
hydrogen next to the carbonyl group. On one hand, 
the addition of a hydrophobic co-solvent such as 
hexane was tested in the presence of triethylamine as 
basic catalyst for the racemization. The organic 
solvent acts as a reservoir for both product and 
substrate, reducing their presence in the aqueous 
phase where the bioreduction occurs, thus favouring 
the solubilization of the substrate and avoiding the 
enzyme inhibition at high substrate concentrations. 
On the other hand, the use of an anion exchange resin 
was considered due to the good racemization 
obtained in the development of dynamic Baeyer-
Villiger oxidation of racemic benzyl ketones 
catalyzed by Baeyer-Villiger monooxygenases.10 
Identical results were achieved using the DOWEX-
MWA-1 and the Amberlite IRA-440C (data not 
shown) in comparison with the previous kinetic 
resolution experiments (Table 2). Aiming for a higher 
racemization rate, the dynamic process was tested at 
higher pHs (9-10). Unfortunately, only a slight 
racemization was found when using the IRA-440C 
resin at pH 9 (data not shown). For that reason, the 
reactions at pH 10 were immediately analyzed in 
depth (Table 3). 
Partial racemization was observed with the 
triethylamine/hexane and the DOWEX systems at 4 
ºC (entries 1-3). Nevertheless, the racemization of the 
remaining ketone was more pronounced with the 
IRA-440C as occurred at pH 9, but now in a higher 
extent (entry 4). Unfortunately the enzyme was 
highly inactivated in these conditions, either at a 
higher enzyme loading (entry 5). For that reason, a 
higher loading of E.coli/ADH-A was considered 
through two different strategies: by using a higher 
reaction temperature and adding the enzyme in one 
portion (entry 6) or stepwise addition of the ADH-A 
(entries 7 and 8), affording in the latter a 27% 
conversion at 4 ºC and a 84% conversion at 30 ºC 
with a good selectivity after 3 days. It must be 
mentioned that the addition of an external 
nicotinamide cofactor was not required for the correct 
action of the E.coli/ADH-A.8c 
At this point, DYRKR experiments were 
conducted over a series of benzyl ketones 2b-m. The 
bioreduction experiments were performed at 30 ºC in 
a Tris-HCl buffer pH 10 using the IRA-440C or the 
DOWEX-MWA-1 resin, and adding in all cases the 
ADH-A in portions over 3 or 4 days. Data are 
depicted in Table 4. As occurred with the formation 
of alcohol 3a, the diastereoisomers syn-(S,S)-3b-m 
were obtained in all cases as major compounds and 
with a perfect enantiomeric excess. In all cases, the 
resins and the ADH were compatible with the pattern 
substitution, only observing some side reactions for 
the IRA-440C resin and the 3-(4’-nitrophenyl)butan-
2-one (2d), affecting the enantiomeric excess of the 
resulting alcohol (entry 8). 
Table 3. DYRKR of racemic ketone 2a using E. coli/ADH-A in a 50 mM Tris-HCl buffer pH 10 at 250 rpm, and 
subsequent intramolecular cyclization catalysed by anhydrous ZnCl2. 
 
Entry ADH-A (mg) Racemization system t (h) T (ºC) c (%)a ee 2a (%)a dr 3ab 
1 5 ----- 24 4 63 86 80:20 
2 5 Et3N/Hexane 24 4 59 60 85:15 
3 5 DOWEX-MWA-1 24 4 58 72 83:17 
4 5 IRA-440C 24 4 11 6 95:5 
5 15 IRA-440C 24 4 15 10 94:6 
6 15 IRA-440C 24 30 43 6 88:12 
7 5+5+5c IRA-440C 72 4 27 22 95:5 
8 5+5+5c IRA-440C 72 30 84 23 88:12 
a Conversion values measured by GC (see Supporting Information for further details) 
b Enantiomeric excess values and diastereomeric ratios syn:anti measured by HPLC (see Supporting Information for 
further details). 
c 5 mg of ADH-A added at 24 and 48 h of reaction. 
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Table 4. DYRKR of racemic ketones 2a-m using E. coli/ADH-A in a 50 mM Tris-HCl buffer pH 10 at 250 rpm. 
 
Entry 2a-m R1 R2 ADH-A 
(mg)a 
Resin t (h) c (%)b ee 3a-m 
(%)c 
dr 3a-mc 
1 2a H Me 5+5+5 IRA-440C 72 84 >99 88:12 
2 2a H Me 5+5+5 DOWEX-MWA-1 72 94 >99 70:30 
3 2b 4-OMe Me 5+5+5 IRA-440C 72 34 >99 91:9 
4 2b 4-OMe Me 5+5+5 DOWEX-MWA-1 72 79 >99 82:18 
5 2c 4-OH Me 5+5+5 IRA-440C 72 47 >99 69:31 
6 2c 4-OH Me 5+5+5 DOWEX-MWA-1 72 38 >99 86:14 
7 2d 4-NO2 Me 5+5+5 IRA-440C 72 67 10 95:5 
8 2d 4-NO2 Me 5+5+5 DOWEX-MWA-1 72 91 >99 95:5 
9 2e 2-OMe Me 5+5+5 IRA-440C 72 4 >99 >99: <1 
10 2e 2-OMe Me 5+5+5 DOWEX-MWA-1 72 52 >99 >99: <1 
11 2f 2-Me Me 5+5+5 IRA-440C 72 14 >99 >99: <1 
12 2f 2-Me Me 5+5+5 DOWEX-MWA-1 72 36 >99 >99: <1 
13 2g 2-F Me 5+5+5 IRA-440C 72 24 >99 97:3 
14 2g 2-F Me 5+5+5 DOWEX-MWA-1 72 90 >99 96:4 
15 2h H Et 5+5+5 IRA-440C 72 67 >99 95:5 
16 2h H Et 5+5+5+5 IRA-440C 96 83 >99 89:11 
17 2h H Et 10+10+10 IRA-440C 72 83 >99 79:21 
18 2h H Et 5+5+5 DOWEX-MWA-1 72 87 >99 68:32 
19 2i H n-Pr 5+5+5 IRA-440C 72 51 >99 96:4 
20 2i H n-Pr 5+5+5 DOWEX-MWA-1 72 86 >99 65:35 
21 2j H Allyl 5+5+5 IRA-440C 72 74 >99 92:8 
22 2j H Allyl 5+5+5+5 IRA-440C 96 89 >99 76:24 
23 2j H Allyl 10+10+10 IRA-440C 72 92 >99 72:28 
24 2k H n-Bu 5+5+5 IRA-440C 72 25 >99 76:24 
25 2k H n-Bu 5+5+5 DOWEX-MWA-1 72 86 >99 57:43 
26 2l H Cy 5+5+5 IRA-440C 72 <3 n.d. n.d. 
27 2m H Bn 5+5+5 IRA-440C  72 18 n.d. n.d. 
a Five or ten mg of ADH-A were added at the starting of the reaction and then five or ten every 24 h. 
b Conversion values measured by GC (see Supporting Information for further details) 
c Enantiomeric excess values and diastereomeric ratios syn:anti measured by HPLC (see Supporting Information for 
further details). n.d.: not determined. 
 
Excellent enantio- and diastereoselectivities were 
found for the C-2 substituted 3-arylbutan-2-ones (2e-
g, entries 9-14). For the IRA-440C resin, the 
bioreduction of ketones with alkyl chains longer than 
butan-2-ones (R2 different than the methyl group) led 
to a significant decrease of the reactivity (entries 15, 
19, 21, 24, 26 and 27), requiring of the addition of 
higher enzyme loadings and longer reaction times to 
reach high conversions into the corresponding 
alcohols (entries 16, 17, 22 and 23). On the contrary, 
the use of DOWEX-MWA-1 provided better 
conversion values (86-87% for 2h, 2i and 2k, entries 
18, 20 and 25) although modest diastereomeric ratios 
were found in these cases. 
Encouraged by the excellent selectivities attained 
with the ADH-A, other alcohol dehydrogenases such 
as commercially available Lactobacillus brevis 
(LBADH) and evo-1.1.200 were tested, enzymes that 
usually act with an opposite anti-Prelog selectivity in 
comparison with the ADH-A.9 Thus, their 
compatibility with the racemization systems (IRA-
440C and DOWEX-MWA-1 anion resins) was 
investigated for the development of efficient DYRKR 
experiments (Table 5). Firstly, control experiments in 
the absence of resin and the use of LBADH and evo-
1.1.200 were studied in the bioreduction of 3-
phenylbutan-2-one (2a) to explore the compatibility 
of these two ADHs with the anion exchange resins 
(entries 1-6), finding a considerable inhibition when 
using the Amberlite IRA-440C, while the 
combination of DOWEX-MWA-1 with the evo-
1.1.200 provided a 72% conversion into the syn-
alcohol (R,R)-3a with excellent enantioselectivity and 
good diastereoselectivity (entry 6). Then, the racemic 
ketones 2b-n were subjected to the DYRKR using the 
same catalytic system, affording the corresponding 
(R,R)-3b-m with moderate to good conversions and 
every high selectivities for most of the cases (entries 
7-18). 
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Table 5. DYRKR of racemic ketones 2a-m using anti-Prelog ADHs in a 50 mM Tris-HCl buffer pH 10 at 250 rpm. 
 
Entry 2a-m R1 R2 ADHa Resin c (%)b ee 3a-m (%)c dr 3a-mc 
1 2a H Me LBADH ----- 47 >99 95:5 
2 2a H Me LBADH IRA-440C 2 >99 n.d. 
3 2a H Me LBADH DOWEX-MWA-1 14 >99 97:3 
4 2a H Me evo-1.1.200 ----- 59 >99 80:20 
5 2a H Me evo-1.1.200 IRA-440C 14 >99 97:3 
6 2a H Me evo-1.1.200 DOWEX-MWA-1 72 >99 80:20 
7 2b 4-OMe Me evo-1.1.200 DOWEX-MWA-1 85 >99 85:15 
8 2c 4-OH Me evo-1.1.200 DOWEX-MWA-1 30 >99 87:13 
9 2d 4-NO2 Me evo-1.1.200 DOWEX-MWA-1 96 >99 >99: <1 
10 2e 2-OMe Me evo-1.1.200 DOWEX-MWA-1 22 >99 >99: <1 
11 2f 2-Me Me evo-1.1.200 DOWEX-MWA-1 16 >99 >99: <1 
12 2g 2-F Me evo-1.1.200 DOWEX-MWA-1 78 >99 >99: <1 
13 2h H Et evo-1.1.200 DOWEX-MWA-1 71 >99 96:4 
14 2i H n-Pr evo-1.1.200 DOWEX-MWA-1 65 >99 97:3 
15 2j H Allyl evo-1.1.200 DOWEX-MWA-1 21 >99 91:9 
16 2k H n-Bu evo-1.1.200 DOWEX-MWA-1 82 >99 98:2 
17 2l H Cy evo-1.1.200 DOWEX-MWA-1 <3 n.d. n.d. 
18 2m H Bn evo-1.1.200 DOWEX-MWA-1 27 n.d. n.d. 
a Three units of  enzyme were added at the starting of the reaction and  every 24 h (total 9 units of enzyme). 
b Conversion values measured by GC (see Supporting Information for further details) 
c Enantiomeric excess values and diastereomeric ratios syn:anti measured by HPLC (see Supporting Information for 
further details). n.d.: not determined. 
Finally, this chemoenzymatic strategy was applied 
to the synthesis of a representative member of the 
isochroman family. The bioreduction reaction of 
racemic ketone 2a was scaled-up from an eppendorf 
tube to a 1 mmol scale at 30 ºC, developing later the 
intramolecular cyclization of the resulting optically 
active alcohol (S,S)-3a (Scheme 2). A sequential 
addition of the enzyme and the presence of external 
cofactor from the beginning was required, observing 
a slower reaction rate in comparison with the 
bioprocess in an eppendorf tube. Nevertheless, after 7 
days and the addition of 100 mg of enzyme every 24 
h, the alcohol (S,S)-3a was obtained with 77% 
conversion (55% isolated yield) and a 88:12 syn:anti 
diastereomeric ratio. Subsequent intramolecular 
cyclization catalyzed by anhydrous zinc chloride in 
methoxymethyl chloride, led to the desired 
isochroman (S,S)-4a in 42% isolated yield and 
without any loss of the optical purity (see Supporting 
Information). 
 
Scheme 2. Chemoenzymatic strategy for the synthesis of 
3,4-dimethylisochroman by a dynamic bioreduction 
followed by intramolecular cyclization. 
Conclusion 
In summary, the chemical synthesis of a series of 
benzyl ketones was developed by reaction of 1-aryl-
propan-2-ones with alkyl halides, to later explore 
their DYRKR using alcohol dehydrogenases and 
anion exchange resins. After optimization of the 
bioreduction and racemization steps, the dynamic 
processes were performed, affording optically active 
alcohols in good conversions, diastereo- and 
stereoselectivities. Remarkably, the creation of two 
stereogenic centers was possible starting from 
structuraly simple racemic ketones. 
The applicability of these valuable compounds was 
demonstrated through the development of a 
chemoenzymatic strategy based on the 
stereocontrolled bioreduction of 3-phenylbutan-2-one 
under basic conditions, followed by intramolecular 
cyclization of the resulting optically active alcohol. 
Thus, (S,S)-3,4-dimethylisochroman was obtained as 
a representative member of this family of oxygenated 
heterocycles. 
Experimental Section 
ADH from Lactobacillus brevis (LBADH, 300 U/mL), was 
obtained from Codexis Inc. ADH evo-1.1.200 (0.42 U/mg) 
was purchased from Evocatal GmbH. ADH-A from 
Rhodococcus ruber was overexpressed in E. coli BL21 
cells and later lyophilized.8 The Amberlite IRA-440 C and 
the DOWEX-MWA-1 anion exchange resins were 
purchased from Sigma-Aldrich. 
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General procedure for the synthesis of racemic ketones 
2a-m.11 To a solution of the corresponding ketone 1a-g (1 
mmol) in a biphasic mixture composed of CH2Cl2 (500 L) 
and an aqueous NaOH 2 M solution (500 L), 
tetrabutylammonium bisulfate (340 mg, 1 mmol) and the 
corresponding alkyl iodide (1.2 mmol) were added. The 
reaction mixture was stirred at 40 ºC for 2 h until no 
starting material was detected by TLC analysis. The 
mixture was extracted afterwards with CH2Cl2 (3 x 10 mL), 
combining the organic layers that were dried over Na2SO4, 
filtered and the solvent evaporated under reduced pressure. 
The resulting reaction crude was purified by column 
chromatography on silica gel (20-50% Et2O/Hexane), 
affording the corresponding alkyl ketones 2a-m (30-84%). 
3-Phenylbutan-2-one (2a). Colourless oil (67%). Rf (50% 
Et2O/Hexane): 0.48. IR (NaCl): 3061, 2954, 1713, 1484, 
1242 and 967 cm-1. 1H NMR (300.13 MHz, CDCl3):  1.39 
(d, 3JHH= 7.0 Hz, 3H), 2.04 (s, 3H), 3.74 (q, 3JHH= 7.0 Hz, 
1H), 6.83-7.75 (m, 5H). 13C NMR (75.5 MHz, CDCl3):  
17.2 (CH3), 28.3 (CH3), 53.7 (CH), 127.1 (CH), 127.8 
(2CH), 128.9 (2CH), 140.6 (C), 208.8 (C). HRMS (ESI+, 
m/z): calcd for (C10H12NaO)+ (M+Na)+: 171.07858 found 
171.07864. 
3-(4’-Methoxyphenyl)butan-2-one (2b). Colourless oil 
(60%). Rf (50% Et2O/Hexane): 0.43. IR (NaCl): 3045, 
2978, 1716, 1367, 1200 and 1083 cm-1. 1H NMR (300.13 
MHz, CDCl3):  1.34 (d, 3JHH= 7.0 Hz, 3H), 2.01 (s, 3H), 
3.67 (q, 3JHH= 7.0 Hz, 1H), 3.76 (s, 3H), 6.85 (d, 3JHH= 8.6 
Hz, 2H), 7.11 (d, 3JHH= 8.7 Hz, 2H). 13C NMR (75.5 MHz, 
CDCl3):  17.0 (CH3), 27.9 (CH3), 52.5 (CH), 54.9 (CH3), 
114.1 (2CH), 128.6 (2CH), 132.4 (C), 158.6 (C), 208.8 (C). 
HRMS (ESI+, m/z): calcd for (C11H14NaO2)+ (M+Na)+: 
201.08915 found 201.0892. 
3-(4’-Hydroxyphenyl)butan-2-one (2c). Yellow oil 
(45%). Rf (50% Et2O/Hexane): 0.59. IR (NaCl): 3361, 
3056, 2944, 1710, 1489, 1075, and 796 cm-1. 1H NMR 
(300.13 MHz, CDCl3):  1.38 (d, 3JHH = 7.0 Hz, 3H), 2.07 
(s, 3H), 3.70 (q, 3JHH = 7.0 Hz, 1H), 6.82 (d, 3JHH = 8.4 Hz, 
2H), 7.10 (d, 3JHH = 8.4 Hz, 2H). 13C NMR (75.5 MHz, 
CDCl3): δ 17.6 (CH3), 28.6 (CH3), 53.3 (CH), 116.2 (CH), 
129.4 (CH), 132.9 (C), 155.3 (C), 210.3 (C). HRMS (ESI+, 
m/z): calcd for (C10H12NaO)+ (M+Na)+: 187.07350 found 
187.07344. 
3-(4’-Nitrophenyl)butan-2-one (2d). Yellow solid (67%). 
Rf (50% Et2O/Hexane): 0.60. IR (NaCl): 3061, 2954, 1720, 
1537, 1359 and 800 cm-1. 1H NMR (300.13 MHz, CDCl3): 
 1.46 (d, 3JHH = 4.6 Hz, 3H), 2.12 (s, 3H), 3.92 (q, 3JHH = 
7.0 Hz, 1H), 7.42 (d, 3JHH = 8.8 Hz, 2H), 8.22 (d, 3JHH = 
8.8 Hz, 2H). 13C NMR (75.5 MHz, CDCl3):  13C NMR 
(75 MHz, CDCl3) δ 17.8 (CH3), 29.1 (CH3), 53.8 (CH), 
124.5 (2CH), 129.2 (2CH), 148.2 (CH), 162.7 (C), 207.4 
(C). HRMS (ESI+, m/z): calcd for (C10H11NNaO3)+ 
(M+Na)+: 216.06366 found 216.06358. 
3-(2’-Methoxyphenyl)butan-2-one (2e). Yellow oil 
(55%). Rf (50% Et2O/Hexane): 0.68. IR (NaCl): 3031, 
2924, 1722, 1055 and 739 cm-1. 1H NMR (300.13 MHz, 
CDCl3):  1.37 (d, 3JHH = 7.0 Hz, 3H), 2.04 (s, 3H), 3.85 (s, 
3H), 4.07 (q, 3JHH = 7.0 Hz, 1H), 6.89-6.98 (m, 2H), 7.14 
(dd, 3JHH = 7.5 Hz; 4JHH = 1.8 Hz, 1H), 7.23-7.29 (m, 1H). 
13C NMR (75.5 MHz, CDCl3):  16.1 (CH3), 28.5 (CH3), 
47.3 (CH), 55.7 (CH3), 111.7 (CH), 121.4 (CH), 128.6 
(CH), 130.0 (C), 157.1 (C), 210.1 (C). HRMS (ESI+, m/z): 
calcd for (C11H14NaO2)+ (M+Na)+: 201.08915 found 
201.08923. 
3-(2’-Methyphenyl)butan-2-one (2f). Yellow oil (55%). 
Rf (50% Et2O/Hexane): 0.68. IR (NaCl): 3058, 2951, 1708, 
1490, 1222 and 742 cm-1. 1H NMR (300.13 MHz, CDCl3): 
 1.37 (d, 3JHH = 6.9 Hz, 3H), 2.02 (s, 3H), 2.40 (s, 3H), 
3.95 (q, 3JHH = 6.9 Hz 1H), 7.05-7.09 (m, 1H), 7.16-7.22 
(m, 3H). 13C NMR (75.5 MHz, CDCl3):  17.0 (CH3), 20.1 
(CH3), 28.7 (CH3), 50.2 (CH), 127.1 (CH), 127.3 (CH), 
127.4 (CH), 131.2 (CH), 139.5 (C), 209.6 (C). HRMS 
(ESI+, m/z): calcd for (C11H14NaO)+ (M+Na)+: 185.09423 
found 185.09418. 
3-(2’-Fluorophenyl)butan-2-one (2g). Colourless oil 
(84%). Rf (50% Et2O/Hexane): 0.58. IR (NaCl): 3029, 
2924, 1718, 1484, 1237 and 750 cm-1. 1H NMR (300.13 
MHz, CDCl3):  1.42 (d, 3JHH = 7.0 Hz, 3H), 2.11 (s, 3H), 
4.08 (q, 3JHH = 7.0 Hz, 1H), 7.07-7.29 (m, 4H). 13C NMR 
(75.5 MHz, CDCl3):  16.0 (CH3), 28.4 (CH3), 45.9 (CH) 
115.5 (d, 2JCF = 22.4 Hz, CH,), 124.6 (CH, d, 4JCF = 3.3 
Hz), 128.8 (d, 3JCF = 7.5 Hz, CH), 129.1 (d, 3JCF = 4.9 Hz, 
CH,), 162.1 (d, 1JCF = 244.6 Hz, C), 207.9 (C). HRMS 
(ESI+, m/z): calcd for (C10H11FNaO)+ (M+Na)+: 189.06916 
found 189.06922. 
3-Phenylpentan-2-one (2h). Yellow oil (56%). Rf (50% 
Et2O/Hexane): 0.69. IR (NaCl): 3027, 2933, 1712, 1493, 
759 and 701 cm-1. 1H NMR (300.13 MHz, CDCl3):  0.86 
(t, 3JHH = 7.4 Hz, 3H), 1.69-1.78 (m, 1H), 2.04-2.14 (m, 
3H), 2.07 (s, 3H), 3.54 (t, 3JHH = 7.4 Hz, 2H), 7.22-7.35 (m, 
5H). 13C NMR (75.5 MHz, CDCl3):  12.0 (CH3), 24.9 
(CH2), 29.0 (CH3), 61.5 (CH), 127.2 (CH), 128.3 (CH), 
128.9 (CH), 139.0 (C), 208.6 (C). HRMS (ESI+, m/z): 
calcd for (C11H14NaO)+ (M+Na)+: 185.09423 found 
185.09427. 
3-Phenylhexan-2-one (2i). Colorless oil (49%). Rf (50% 
Et2O/Hexane): 0.70. IR (NaCl): 3060, 2957, 1715, 1491, 
1161, 746 and 701 cm-1. 1H NMR (300.13 MHz, CDCl3):  
0.90 (t, 3JHH = 7.3 Hz, 3H), 1.15-1.27 (m, 2H) 1.63-1.76 (m, 
1H), 1.96-2.08 (m, 1H), 2.07 (s, 3H), 3.63 (t, 3JHH = 7.4 Hz, 
1H), 7.21-7.37 (m, 5H). 13C NMR (75.5 MHz, CDCl3):  
14.4 (CH3), 21.0 (CH2), 29.4 (CH3), 34.3 (CH2), 60.0 (CH), 
127.5 (CH), 128.6 (CH), 129.2 (CH), 139.5 (C), 209.0 (C). 
HRMS (ESI+, m/z): calcd for (C12H16NaO)+ (M+Na)+: 
199.10988 found 199.10991. 
3-Phenylhex-5-en-2-one (2j). Yellow oil (54%). Rf (50% 
Et2O/Hexane): 0.71. IR (NaCl): 3063, 2977, 1716, 1641, 
1161, 749 and 700 cm-1. 1H NMR (300.13 MHz, CDCl3):  
2.07, (s, 3H), 2.40-2.50 (m, 1H), 2.77-2.86 (m, 1H), 3.71 (t, 
3JHH = 7.5 Hz, 1H), 4.94-5.06 (m, 2H), 5.62-5.75 (m, 2H), 
7.21-7.38 (m, 5H). 13C NMR (75.5 MHz, CDCl3):  29.5 
(CH3), 36.5 (CH2), 59.8 (CH), 116.9 (CH2), 127.7 (CH), 
128.7 (CH), 129.3 (CH), 136.1 (CH), 138.7 (C), 208.0 (C). 
HRMS (ESI+, m/z): calcd for (C12H14NaO)+ (M+Na)+: 
197.09423 found 197.09421. 
3-Phenylheptan-2-one (2k). Yellow oil (60%). Rf (50% 
Et2O/Hexane): 0.70. IR (NaCl): 3056, 2977, 1710, 1355, 
1117, 731 and 698 cm-1. 1H NMR (300.13 MHz, CDCl3):  
0.86 (t, 3JHH = 7.1 Hz, 3H), 1.10-1.35 (m, 4H), 1.62-1.77 
(m, 2H), 2.06 (s, 3H), 3.61 (t, 3JHH = 7.4 Hz, 3H), 7.21-
7.38 (m, 5H). 13C NMR (75.5 MHz, CDCl3):  14.3 (CH3), 
22.7 (CH2), 29.4 (CH3), 30.0 (CH2), 31.9 (CH2), 60.2 (CH), 
127.5 (CH), 128.6 (CH), 129.2 (CH), 139.5 (C), 209.0 (C). 
HRMS (ESI+, m/z): calcd for (C13H18NaO)+ (M+Na)+: 
213.12553 found 213.12558. 
1-Cyclohexyl-1-phenylpropan-2-one (2l). Yellow oil 
(30%). Rf (50% Et2O/Hexane): 0.69. IR (NaCl): 3061, 
2964, 1719, 1355, 732 and 696 cm-1. 1H NMR (300.13 
MHz, CDCl3):  0.68-0.81 (m, 1H), 0.91-1.04 (m, 1H), 
1.11-1.21 (m, 2H), 1.25-1.40 (m, 2H), 1.60-1.75 (m, 3H), 
1.79-1.89 (m, 1H), 2.10 (s, 3H), 2.05-2.19 (m, 1H), 3.42 (d, 
3JHH = 10.4 Hz 1H), 7.22-7.38 (m, 5H). 13C NMR (75.5 
MHz, CDCl3):  26.1 (CH2), 26.4 (CH2), 30.4 (CH3), 30.5 
(CH2), 32.2 (CH2), 39.5 (CH), 66.5 (CH), 127.1 (CH), 
128.7 (CH), 128.8 (CH), 137.5 (C), 208.8 (C). HRMS 
(ESI+, m/z): calcd for (C15H20NaO)+ (M+Na)+: 239.14118 
found 239.14113. 
3,4-Diphenylbutan-2-one (2m). Yellow oil (40%). Rf 
(50% Et2O/Hexane): 0.63. IR (NaCl): 3058, 2958, 1735 
and 696 cm-1. 1H NMR (300.13 MHz, CDCl3):  2.06 (s, 
3H), 2.93 (dd, 2JHH = 13.8 Hz, 3JHH = 7.4 Hz 1H), 3.46 (dd, 
3JHH = 13.8 Hz, 2JHH = 7.4 Hz 1H), 3.95 (t, 3JHH = 7.4 Hz, 
1H), 7.05-7.09 (m, 2H), 7.17-7.24 (m, 4H), 7.29-7.36 (m, 
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3H). 13C NMR (75.5 MHz, CDCl3):  29.9 (CH2), 38.7 
(CH2), 61.9 (CH), 126.5 (CH), 127.8 (CH), 128.6 (CH), 
128.7 (CH), 129.3 (CH), 129.4 (CH), 138.9 (C), 140.1 (C), 
208.8 (C). HRMS (ESI+, m/z): calcd for (C16H16NaO)+ 
(M+Na)+: 247.10988 found 247.11001. 
General procedure for the synthesis of racemic alcohols 
3a-m. To a solution of racemic ketones 2a-m (1 mmol) in 
dry MeOH (10 mL), sodium borohydride (38 mg, 1 mmol) 
was carefully added under nitrogen atmosphere. The 
mixture was stirred for 2 h until no starting material was 
detected by TLC analysis (50% Et2O/Hexane). The 
reaction was quenched afterwards with H2O (10 mL) and 
extracted with CH2Cl2 (3 x 10 mL). The organic layers 
were combined, dried over Na2SO4, filtered and the solvent 
evaporated under reduced pressure. The resulting reaction 
crude was purified by column chromatography on silica 
gel (50% Et2O/Hexane), affording the corresponding 
racemic alcohols 3a-m (90-99%). 
3-Phenylbutan-2-ol (3a). Colourless oil (93%). Rf (50% 
Et2O/Hexane): 0.32. Diastereomeric ratio for (±)-3a 
(syn:anti): 20:80. IR (NaCl): 3373, 3065, 2969, 1472, 1374 
and 935 cm-1. 1H NMR (300.13 MHz, CDCl3):  1.10 (d, 
3JHH= 6.3 Hz, 3H, syn), 1.24 (d, 3JHH= 6.2 Hz, 3H, anti), 
1.28 (d, 3JHH= 7.0 Hz, 3H, anti), 1.34 (d, 3JHH= 7.1 Hz, 3H, 
syn), 1.56 (br s, 1H, syn+anti), 2.44-3.29 (m, 1H, syn+anti), 
3.49-4.30 (m, 1H, syn+anti), 6.86-7.68 (m, 5H, syn+anti). 
13C NMR (75.5 MHz, CDCl3):  16.0 (CH3, syn), 17.8 
(CH3, anti), 20.5 (CH3, anti), 21.0 (CH3, syn), 47.1 (CH, 
syn), 47.9 (CH, anti), 72.3 (CH, syn+anti), 126.4 (CH, syn), 
126.7 (CH, anti), 127.8 (2CH, syn), 128.0 (2CH, anti), 
128.3 (2CH, syn), 128.5 (2CH, anti), 143.5 (C, anti), 144.2 
(C, syn). HRMS (ESI+, m/z): calcd for (C10H14NaO)+ 
(M+Na)+: 173.0397 found 173.0390. 
3-(4’-Methoxyphenyl)butan-2-ol (3b). Colourless oil 
(96%). Rf (50% Et2O/Hexane): 0.28. Diastereomeric ratio 
for (±)-3b (syn:anti): 16:84. IR (NaCl): 3390, 3045, 2967, 
1477, 1267 and 990 cm-1. 1H NMR (300.13 MHz, CDCl3): 
 1.07 (d, 3JHH= 6.3 Hz, 3H, syn), 1.21 (d, 3JHH= 6.2 Hz, 
3H, anti), 1.24 (d, 3JHH= 7.1 Hz, 3H, anti), 1.29 (d, 3JHH= 
7.1 Hz, 3H, syn), 1.50 (br s, 1H, syn+anti), 2.52-2.78 (m, 
1H, syn+anti), 3.63-3.95 (m, 4H, syn+anti), 6.77-6.97 (m, 
2H, syn+anti), 7.06-7.20 (m, 2H, syn+anti). 13C NMR 
(75.5 MHz, CDCl3):  16.2 (CH3, syn), 18.0 (CH3, anti), 
20.6 (CH3, anti), 20.9 (CH, syn), 46.2 (CH, syn), 47.1 (CH, 
anti), 55.3 (CH3, syn+anti), 72.4 (CH, syn+anti), 113.8 
(2CH, syn), 114.0 (2CH, anti), 128.7 (CH, syn), 129.0 (CH, 
anti), 135.3 (C, anti),136.1 (C, syn), 158.0 (C, syn), 158.2 
(C, anti). HRMS (ESI+, m/z): calcd for (C11H16NaO2)+ 
(M+Na)+: 203.1043 found 203.1053. 
3-(4’-Hydroxybutan-2-yl)phenol (3c). Colourless oil 
(93%). Rf (50% Et2O/Hexane): 0.39. Diastereomeric ratio 
for (±)-3c (syn:anti): 14:86. IR (NaCl): 3361, 3056, 2944, 
1488, 1076, and 797 cm-1. 1H NMR (300.13 MHz, CDCl3): 
 1.24-1.32 (m, 6H, anti+syn), 1.50 (br s, 1H, anti+syn), 
2.59-2.75 (m, 1H, syn+anti), 3.77-3.89 (m, 1H, syn+anti), 
6.78-6.82 (m, 2H, syn+anti), 7.09-7.13 (m, 2H, syn+anti). 
13C NMR (75.5 MHz, CDCl3):  16.4 (CH3, syn), 18.4 
(CH3, anti), 20.1 (CH3, syn+anti), 47.5 (CH3, syn+anti), 
73.1 (CH, syn+anti), 115.9 ( 2CH, syn+anti), 129.5 (2CH, 
syn+anti), 135.6 (C, syn+anti), 155.0 (C, syn+anti). 
HRMS (ESI+, m/z): calcd for (C10H14NaO2)+ (M+Na)+: 
189.08915 found 189.08920. 
3-(4’-Nitrophenyl)butan-2-ol (3d). Colourless oil (96%). 
Rf (50% Et2O/Hexane): 0.53. Diastereomeric ratio for (±)-
3d (syn:anti): 23:77. IR (NaCl): 3360, 3055, 2969, 1473, 
1374, 1222 and 860 cm-1. 1H NMR (300.13 MHz, CDCl3): 
 1.11 (d, 3JHH= 6.3 Hz, 3H, syn), 1.23 (d, 3JHH= 6.2 Hz, 
3H, anti), 1.33 (d, 3JHH= 7.1 Hz, 3H, anti), 1.37 (d, 3JHH= 
7.0 Hz, 3H, syn), 1.50 (br s, 1H, syn+anti), 2.80-2.92 (m, 
1H, syn+anti), 3.93-3.99 (m, 1H, syn+anti), 7.38-7.45 (m, 
2H, syn+anti), 8.16-8.20 (m, 2H, syn+anti). 13C NMR 
(75.5 MHz, CDCl3):  15.6 (CH3, syn), 17.7 (CH3, anti), 
21.2 (CH3, anti), 21.3 (CH3, syn), 47.1 (CH, syn), 47.5 (CH, 
anti), 71.8 (CH, syn), 71.9 (CH, anti), 123.6 ( 2CH, 
syn+anti), 128.7 (2CH, syn), 129.0 (2CH, anti), 146.7 (C, 
syn+anti), 151.8 (C, syn+anti). HRMS (ESI+, m/z): calcd 
for (C10H13NNaO3)+ (M+Na)+: 218.07931 found 218.07928. 
3-(2’-Methoxyphenyl)butan-2-ol (3e). Yellow oil (99%). 
Rf (50% Et2O/Hexane): 0.47. Diastereomeric ratio for (±)-
3f (syn:anti): 13:87. IR (NaCl): 3390, 3045, 2967, 1477, 
1267 and 742 cm-1. 1H NMR (300 MHz, CDCl3) δ, , 1.12 
(d, J = 6.3 Hz, 3H, syn), 1.22 (d, J = 6.2 Hz, 3H, anti), 1.26 
(d, J = 7.2 Hz, 3H, anti), 1.30 (d, J = 7.2 Hz, 3H, syn), 1.86 
(brs, 1H, syn+anti), 3.21-3.33 (m, 1H, syn+anti), 3.85 (s, 
3H, syn+anti) 3.92-4.01 (m, 1H, syn+anti), 6.89-7.00 (m, 
2H, syn+anti), 7.19-7.26 (m, 2H, syn+anti). 13C NMR 
(75.5 MHz, CDCl3):  15.2 (CH3, syn), 17.1 (CH3, anti), 
21.0 (CH3, syn), 21.1 (CH3, anti),39.8 (CH, syn), 40.8 (CH, 
anti), 55.8 (CH, anti+syn), 111.0 (CH, syn), 111.1 (CH, 
anti), 121.1 (CH, syn), 121.3 (CH, anti), 127.6 (CH, syn), 
127.8 (CH, anti), 128.6 (anti+syn), 132.1 (C, syn), 132.3 
(C, anti), 157.4 (C, syn), 157.8 (C, anti). HRMS (ESI+, 
m/z): calcd for (C11H16NaO2)+ (M+Na)+: 203.10480 found 
203.10487. 
3-(2’-Methylphenyl)butan-2-ol (3f). Colourless oil (90%). 
Rf (50% Et2O/Hexane): 0.47. Diastereomeric ratio for (±)-
3g (syn:anti): 13:87. IR (NaCl): 3203, 2951, 1490, 1222, 
1035 and 742 cm-1. 1H NMR (300.13 MHz, CDCl3):  1.14 
(d, 3JHH = 6.3 Hz, 3H, syn), 1.22 (d, 3JHH = 7.0 Hz, 3H, 
anti), 1.30 (d, 3JHH= 6.1 Hz, 3H, syn+anti), 1.69 (br s, 1H, 
syn+anti), 2.36 (s, 3H, syn) 2.39 (s, 3H, anti), 2.91-3.24 (m, 
1H, syn+anti), 3.92-3.96 (m, 1H, syn+anti), 7.13-7.30 (m, 
4H, syn+anti): 13C NMR (75.5 MHz, CDCl3):  18.3 (CH3, 
syn+anti), 20.3 (CH3, syn+anti), 20.9 (CH3, syn+anti), 40.0 
(CH, syn+anti), 72.7 (CH, syn+anti), 126.2 (CH, syn+anti), 
126.6 (CH, syn+anti), 126.9 (CH, syn+anti), 137.2 (C, 
syn+anti), 142.5 (C, syn+anti). HRMS (ESI+, m/z): calcd 
for (C11H16NaO)+ (M+Na)+: 187.10988 found 187.10978. 
3-(2’-Fluorophenyl)butan-2-ol (3g). Colourless oil (97%). 
Rf (50% Et2O/Hexane): 0.51. Diastereomeric ratio for (±)-
3h (syn:anti): 16:84. IR (NaCl): 3350, 2920, 1489, 1237 
and 752 cm-1. 1H NMR (300.13 MHz, CDCl3):  1H NMR 
(300 MHz, CDCl3) δ, , 1.14 (d, J = 6.3 Hz, 3H, syn), 1.23 
(d, J = 6.2 Hz, 3H,anti), 1.31 (d, J = 7.2 Hz, 3H, anti), 1.36 
(d, J = 7.1 Hz, 3H, syn), 1.55 (brs, 1H, syn+anti), 3.09-3.18 
(m, 1H, syn+anti), 3.95-4.03 (m, 1H, syn+anti), 7.03-7.34 
(m, 4H, syn+anti). 13C NMR (75.5 MHz, CDCl3):  15.1 
(CH3, syn), 16.8 (CH3, anti), 20.8 (CH3, anti), 21.1 (CH3, 
syn) 40.0 (CH, syn), 40.3 (CH, anti), 71.3 (CH, anti), 71.4 
(CH, syn) 115.5 (d, 2JCF = 23.2 Hz, CH, syn+anti), 124.2 
(CH, d, 4JCF = 3.2 Hz syn+anti), 127.9 (d, 3JCF = 8.4 Hz, 
CH, syn+anti), 129.1 (d, 3JCF = 4.9 Hz, CH, syn+anti), 
130.3 (C, syn+anti), 161.1 (d, 1JCF = 244.6 Hz, C, 
syn+anti). HRMS (ESI+, m/z): calcd for (C10H13FNaO)+ 
(M+Na)+: 191.19779 found 191.19786. 
3-Phenylpentan-2-ol (3h). Colourless oil (97%). Rf (50% 
Et2O/Hexane): 0.57. Diastereomeric ratio for (±)-3i 
(syn:anti): 19:81. 3227, 1493, 1050, 740 and 703 cm-1. 1H 
NMR (300.13 MHz, CDCl3):  0.78 (t, 3JHH = 7.4 Hz, 3H, 
syn+anti), 1.23 (d, 3JHH= 6.2 Hz, 3H, syn+anti), 1.37 (br s, 
1H, syn+anti), 1.61-1.71 (m, 1H, syn+anti), 1.76-1.86 (m, 
1H, syn+anti), 2.39-2.47 (m, 1H, syn+anti), 3.90-3.99 (m, 
1H, syn+anti), 7.22-7.29 (m, 3H, syn+anti), 7.33-7.38 (m, 
2H, syn+anti). 13C NMR (75.5 MHz, CDCl3):  12.6 (CH3, 
syn+anti), 21.5 (CH3, syn+anti), 25.2 (CH2, syn+anti), 56.4 
(CH, syn+anti), 71.5 (CH, syn+anti), 127.1 (CH, syn+anti), 
128.9 (CH, syn+anti), 129.3 (CH, syn+anti), 141.7 (C, 
syn+anti). HRMS (ESI+, m/z): calcd for (C11H16NaO)+ 
(M+Na)+: 187.10988 found 187.10993. 
3-Phenylhexan-2-ol (3i). Yellow oil (98%). Rf (50% 
Et2O/Hexane): 0.60. Diastereomeric ratio for (±)-3j 
(syn:anti): 15:85. IR (NaCl): 3350, 2957, 1487, 1051, 748 
and 703 cm-1. 1H NMR (300.13 MHz, CDCl3):  0.85 (t, 
3JHH = 7.3 Hz, 3H, syn+anti), 1.10-1.20 (m, 2H, syn+anti), 
1.23 (d, 3JHH= 6.2 Hz, 3H, syn+anti), 1.37 (br s, 1H, 
syn+anti), 1.61-1.71 (m, 1H, syn+anti), 1.76-1.86 (m, 1H, 
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syn+anti), 2.50-2.57 (m, 1H, syn+anti), 3.90-3.99 (m, 1H, 
syn+anti), 7.22-7.29 (m, 3H, syn+anti), 7.33-7.38 (m, 2H, 
syn+anti). 13C NMR (75.5 MHz, CDCl3):  14.5 (CH3, 
syn+anti), 21.1 (CH2, syn+anti), 21.5 (CH3, syn+anti), 33.7 
(CH2, syn), 34.5 (CH2, anti),  54.0 (CH, syn), 54.2 (CH, 
anti), 71.7 (CH, anti), 72.2 (CH, syn), 126.8 (CH, syn), 
127.1 (CH, anti), 128.7 (CH, syn), 128.9 (CH, anti), 129.2 
(CH, syn+anti), 142.0 (C, syn+anti). HRMS (ESI+, m/z): 
calcd for (C12H18NaO)+ (M+Na)+: 201.12553 found 
201.12556. 
3-Phenyl-hex-5-en-2-ol (3j). Yellow oil (98%). Rf (50% 
Et2O/Hexane): 0.48. IR (NaCl): 3323, 2977, 1641, 1161, 
760 and 702 cm-1. Diastereomeric ratio for (±)-3k 
(syn:anti): 21:79 1H NMR (300.13 MHz, CDCl3):  1.07, 
(d, 3JHH = 6.3 Hz, 3H, syn), 1.21, (d, 3JHH = 6.3 Hz, 3H, 
anti) 1.53 (brs, 1H), 2.46-2.69 (m, 2H, syn+anti), 3.98-
4.02 (m, 1H, syn+anti), 4.92-5.06 (m, 2H, syn+anti), 5.59-
5.70 (m, 1H, syn+anti), 7.17-7.38 (m, 5H). 13C NMR (75.5 
MHz, CDCl3):  21.5 (CH3, syn+anti), 35.9 (CH2, syn), 
36.8 (CH2, anti), 53.8 (CH, anti), 53.9 (CH, syn), 70.4 (CH, 
anti), 70.5 (CH, syn), 116.3 (CH2,syn), 116.6 (CH2, anti), 
127.0 (CH, syn), 127.2 (CH, anti), 128.8 (CH, syn), 128.9 
(CH, anti), 129.0 (CH, syn) 129.4 (CH, anti), 137.0 (CH, 
anti), 137.4 (CH, syn), 141.1 (C); HRMS (ESI+, m/z): calcd 
for (C12H16NaO)+ (M+Na)+: 199.10988 found 199.10991. 
3-Phenylheptan-2-ol (3k). Colourless oil (95%). Rf (50% 
Et2O/Hexane): 0.62. Diastereomeric ratio for (±)-3l 
(syn:anti): 14:86. IR (NaCl): 3366, 2917, 1399, 1061, 743 
and 700 cm-1. 1H NMR (300.13 MHz, CDCl3):  0.85 (t, 
3JHH = 7.2 Hz, 3H, syn+anti), 1.04-1.18 (m, 2H, syn+anti), 
1.23 (d, 3JHH= 6.3 Hz, 3H, syn+anti), 1.26-1.34 (m, 2H, 
syn+anti) 1.45 (br s, 1H, syn+anti), 1.64-1.76 (m, 2H, 
syn+anti), 2.48-2.55 (m, 1H, syn+anti), 3.89-3.97 (m, 1H, 
syn+anti), 7.22-7.29 (m, 3H, syn+anti), 7.33-7.41 (m, 2H, 
syn+anti). 13C NMR (75.5 MHz, CDCl3):  14.3 (CH3, 
syn+anti), 21.5 (CH3, syn+anti), 23.1 (CH2, syn+anti), 30.1 
(CH2, syn+anti), 32.0 (CH2, syn+anti), 54.5 (CH, 
syn+anti), 71.7 (CH, syn+anti), 127.1 (CH, syn+anti), 
128.7 (CH, syn+anti), 129.2 (CH, syn+anti), 142.0 (C, 
syn+anti). HRMS (ESI+, m/z): calcd for (C13H20NaO)+ 
(M+Na)+: 215.14118 found 215.14109. 
1-Cyclohexyl-1-phenylpropan-2-ol (3l). Yellow oil 
(90%). Rf (50% Et2O/Hexane): 0.55. IR (NaCl): 3389, 
2964, 1352, 729 and 695 cm-1. 1H NMR (300.13 MHz, 
CDCl3):  0.78-2.05 (m, 10H), 1.08 (d, 3JHH = 6.3 Hz, 3H), 
2.27 (dd, 3JHH = 8.4 Hz, 3JHH = 5.1 Hz, 1H), 4.30-4.38 (m, 
1H), 7.20-7.35 (m, 5H). 13C NMR (75.5 MHz, CDCl3):  
22.5 (CH3), 26.5 (CH2), 26.6 (CH2), 30.8 (CH2), 31.9 
(CH2) 59.3 (CH), 66.6 (CH), 126.8 (CH), 128.5 (CH), 
130.2 (CH), 140.5 (C). HRMS (ESI+, m/z): calcd for 
(C15H22NaO)+ (M+Na)+: 241.15683 found 241.15868. 
3,4-Diphenylbutan-2-ol (3m). Yellow oil (96%). Rf (50% 
Et2O/Hexane): 0.50. IR (NaCl): 3395, 2961, 1352, 729, 
699 and 695 cm-1cm-1. 1H NMR (300.13 MHz, CDCl3):  
1.22 (d, 3JHH = 6.3 Hz, 3H), 1.41 (brs, 1H),2.84-3.02 (m, 
2H), 3.22 (dd, 2JHH = 13.3 Hz, 3JHH = 6.5 Hz, 1H), 4.02-
4.06 (m, 1H), 7.10-7.36 (m, 9H). 13C NMR (75.5 MHz, 
CDCl3):  22.0 (CH3), 39.0 (CH2), 55.7 (CH), 69.9 (CH), 
126.3 (CH), 127.2 (CH), 128.6 (CH), 128.8 (CH), 129.5 
(CH), 129.6 (CH), 140.8 (C), 141.0 (C). HRMS (ESI+, 
m/z): calcd for (C16H18NaO)+ (M+Na)+: 249.12553 found 
249.12558. 
General procedure for the kinetic resolution of racemic 
ketones 2a using E. coli/ ADH-A. E. coli/ADH-A cells 
(15 mg) were rehydrated in an eppendorf tube with a 50 
mM Tris-HCl buffer (500 µL) at different pHs. The 
mixture was shaken at 250 rpm for 30 min and after this 
time the corresponding ketone 2a (0.01 mmol), 2-propanol 
(25 µL), hexane (25 µL) and a 10 mM solution of NADH 
in the corresponding Tris-HCl buffer (50 L) were 
successively added. The reaction was shaken at 250 rpm 
and 30 ºC, measuring the conversion values by GC 
analysis. 
General procedure for the dynamic reductive kinetic 
resolution of racemic ketones 2a-m using E. coli/ADH-
A. In an eppendorf tube containing rehydrated E. 
coli/ADH-A cells (5 or 10 mg) in a 50 mM Tris-HCl buffer 
(500 µL) at different pHs, the corresponding ketone 2a-m 
(0.01 mmol), 2-propanol (25 µL), IRA-440C resin (12 mg) 
or DOWEX-MWA-1 resin (12 mg) were successively 
added. The reaction was shaken at 250 rpm and 30 ºC, 
adding additional enzyme (5 or 10 mg) every 24 h. The 
conversion values into the corresponding alcohols (S,S)-
3a-m were measured by GC analysis, and their optical 
purity by HPLC analysis. 
Scale-up dynamic reductive kinetic resolution of 
racemic ketones 2a using E. coli/ ADH-A. To a solution 
containing rehydrated E. coli/ADH-A cells (100 mg/mmol, 
100 mg) in a 50 mM Tris-HCl buffer pH 10 (0.05 M, 19 
mL), 2-propanol (5% v/v, 1 mL), IRA-440C resin (100 
mg), NADH (1 mM, 14 mg) and the racemic ketone 2a (1 
mmol) were successively added. The reaction was shaken 
for 24 h and 250 rpm. Then, additional E. coli/ADH-A 
cells (100 mg) were added every 24 h during 7 days. The 
process was monitored by GC analysis. After seven days, 
the mixture was centrifuged and extracted with EtOAc (3 x 
15 mL). Organic layers were combined, dried over 
Na2SO4, filtered and the solvent was removed under 
reduced pressure. The resulting reaction crude was purified 
by column chromatography on silica gel (50% 
Et2O/Hexane), affording the corresponding optically active 
(S,S)-alcohol 3a. []20D +8.7 (c 1, CHCl3), >99% ee 
(diastereomeric ratio syn:anti 88:12). 
General procedure for the dynamic reductive kinetic 
resolution of racemic ketones 2a-m using evo.1.1.200 
ADH. To a solution of the corresponding ketone 2a-m 
(0.01 mmol) in a Tris-HCl buffer (325 µL) at different pHs 
in an eppendorf tube, 2-propanol (25 µL), IRA-440C resin 
(12 mg) or DOWEX-MWA-1 resin (12 mg), a 10 mM 
MgCl2 solution (50 µL), a 10 mM NADH solution (50 µL) 
and a stock evo-1.1.200 solution (3 U every 24 h) were 
successively added. The mixture was shaken at 250 rpm 
and 30 ºC for 72 h. After this time, the reaction was 
extracted with EtOAc (3 x 0.5 mL). Organic layers were 
collected, dried over Na2SO4 and filtered, measuring the 
conversions values into the corresponding alcohols (R,R)-
3a-m by GC analysis, and their optical purity by HPLC 
analysis. 
General procedure for the dynamic reductive kinetic 
resolution of racemic ketones 2a-m using ADH from 
Lactobacillus brevis. To a solution of the corresponding 
ketone 2a-m (0.01 mmol) in a 50 mM Tris-HCl buffer (336 
µL) at different pHs in an eppendorf tube, 2-propanol (32 
µL), IRA-440C resin (12 mg) or DOWEX-MWA-1 resin 
(12 mg), a 10 mM MgCl2 solution (50 µL), a 10 mM 
NADPH solution (60 µL) and a LBADH solution (3 U 
every 24 h) were successively added. The mixture was 
shaken at 250 rpm and 30 ºC for 72 h. After this time, the 
reaction was extracted with EtOAc (3 x 0.5 mL). Organic 
layers were collected, dried over Na2SO4, filtered, 
measuring the conversions values into the corresponding 
alcohols (R,R)-3a-m by GC analysis, and their optical 
purity by HPLC analysis. 
General procedure for the cyclization of alcohol 3a. To 
a solution of the alcohol racemic or (S,S)-3a (100 mg, 0.74 
mmol) in methoxymethyl chloride (1.64 mL, 19 mmol), 
anhydrous ZnCl2 (43 mg, 0.32 mmol) was added at room 
temperature under nitrogen atmosphere. The mixture was 
stirred for 15 min until no starting material was detected by 
TLC analysis (50% Et2O/Hexane). The reaction was 
quenched afterwards with H2O (10 mL) at 0 ºC and 
extracted with Et2O (3 x 10 mL). Organic layers were 
collected, dried over Na2SO4, filtered, and the solvent 
evaporated under reduced pressure. The reaction crude was 
finally purified by column chromatography on silica gel 
(5% Et2O/Hexane), affording the 3,4-dimethylisochroman 
(4a) as a colorless oil (53 mg, 44%). Rf (5% Et2O/Hexane): 
0.22. Diastereomeric ratio for (±)-4a syn:anti 88:12. IR 
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(NaCl): 3068, 2978, 1616, 1380, 1035 and 809 cm-1. 1H 
NMR (300.13 MHz, CDCl3):  1.24 (d, 3JHH= 7.1 Hz, 3H, 
syn), 1.31 (d, 3JHH= 6.9 Hz, 3H, anti), 1.32 (d, 3JHH= 6.4 
Hz, 3H, syn), 1.40 (d, 3JHH= 6.2 Hz, 3H, anti), 2.57-2.83 
(m, 1H, syn+anti), 3.53 (dq, 3JHH= 8.7, 6.1 Hz, 1H, anti), 
3.92 (qd, 3JHH= 6.4, 2.8 Hz, 1H, syn), 4.82 (s, 3H, anti), 
4.87 (s, 3H, syn), 6.97-7.04 (m, 1H, syn+anti), 7.13-7.34 
(m, 3H, syn+anti). 13C NMR (75.5 MHz, CDCl3):  16.3 
(CH3, syn), 17.6 (CH3, anti), 18.1 (CH3, syn), 19.7 (CH3, 
anti), 36.6 (CH, syn), 38.0 (CH, anti), 67.5 (CH2, anti), 
68.4 (CH2, syn), 72.8 (CH, syn), 77.0 (CH, anti), 123.9 
(CH, anti), 124.0 (CH, syn), 125.7 (CH, anti), 126.0 (CH, 
syn), 126.4 (CH, syn), 126.7 (CH, anti), 127.2 (CH, anti), 
128.8 (CH, syn), 134.0 (C, syn), 134.3 (C, anti), 138.1 (C, 
anti), 140.6 (C, syn). HRMS (ESI+, m/z): calcd for 
(C11H14NaO)+ (M+Na)+: 185.0937 found 185.0943. []20D 
+85.8 (c 1, CHCl3), >99% ee for the (S,S)-diasteroisomer 
(diastereomeric ratio syn:anti 88:12). 
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